Cevec Pharmaceuticals this week announced the appointment of Rainer Lichtenberger as CEO, replacing Stefan Kochanek, a founder of the company, who had served as interim CEO.
Lichtenberg most recently was CEO of German biopharmaceutical development company Neuraxo Biotec. He also has held various positions, including vice president of strategic marketing and corporate vice president of business development at the Merckle/ratiopharm group and Merck.
Kochanek will continue to serve as a board member.
Cevec, based in Cologne, Germany, develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.